TB-500
Recovery requires more than controlling inflammation. Repair cells must move into damaged tissue, blood flow must support the healing environment, and new tissue must be organized and remodeled.
TB-500 has generated interest because of its relationship to biological pathways involved in cell migration, cytoskeletal organization, wound-repair signaling, and tissue remodeling.
Experimental • Human clinical evidence remains limitedWhat Is TB-500?
TB-500 is a synthetic seven-amino-acid peptide with the sequence Ac-LKKTETQ.
Research interest centers on biological processes involved in cellular movement, cytoskeletal organization, and the coordinated response to tissue injury.
This makes TB-500 particularly interesting within discussions of musculoskeletal recovery, wound repair, tissue remodeling, and regenerative biology.
Why Is TB-500 Interesting for Recovery?
Tissue recovery is a coordinated process. Cells must migrate into an injured region, organize themselves, communicate with neighboring cells, support vascular responses, and gradually rebuild the extracellular environment.
TB-500 research interest focuses on several parts of this process.
Cellular Migration
Repair requires fibroblasts, endothelial cells, immune cells, and other cells to move toward areas of tissue injury.
Cytoskeletal Organization
The internal structure of a cell helps determine how it changes shape, moves, attaches, and organizes during repair.
Repair Environment
Injured tissue requires adequate circulation, cellular communication, nutrients, oxygen, and coordinated repair signaling.
Tissue Remodeling
Newly repaired tissue must eventually be organized and remodeled so it can tolerate normal mechanical demands.
Proposed Biology vs. Proven Clinical Effect
These pathways explain why TB-500 has generated interest in recovery research. They should not be interpreted as proof that TB-500 accelerates healing in humans.
Areas of Research Interest
Muscle Recovery
Cell migration, tissue organization, vascular support, and remodeling make skeletal-muscle recovery an area of interest. Human clinical effectiveness has not been established.
Tendon & Ligament Recovery
TB-500 is frequently discussed in connective-tissue recovery, but controlled human trials have not established faster tendon or ligament healing.
Wound Repair
Wound healing has been a major area considered in the regulatory evaluation of TB-500, although direct therapeutic evidence remains limited.
Tissue Remodeling
The ability of repair cells to migrate and reorganize tissue provides the rationale for interest in broader regenerative and remodeling applications.
What Does the Evidence Actually Show?
Evidence Rating: Experimental
The biological rationale is interesting, but the current evidence does not justify describing TB-500 as a clinically proven regenerative therapy.
Administration in Research & Compounding Discussions
Subcutaneous & Intramuscular
Subcutaneous and intramuscular administration were the routes proposed in the TB-500 compounding nomination reviewed by FDA.
TB-500 does not have an FDA-approved route, dose, treatment cycle, or commercially approved drug formulation.
Safety & Important Considerations
The absence of a large human clinical database makes it difficult to predict the full adverse-effect profile or long-term risks of TB-500.
Human Safety Data
Published human safety data are insufficient to establish the frequency or severity of potential adverse effects.
Immunogenicity
Injectable peptides may create immunologic concerns, particularly when aggregation or peptide-related impurities are present.
Product Purity
Identity, concentration, peptide-related impurities, aggregates, and manufacturing quality are important considerations.
Injectable Sterility
Sterility, bacterial endotoxins, particulates, and contamination are important safety considerations for injectable products.
Drug Interactions
Potential interactions with medications, supplements, or other peptides have not been comprehensively characterized.
Long-Term Exposure
Long-term or repeated human exposure has not been adequately studied.
FDA & Regulatory Status
Not FDA Approved
TB-500 is not a component of an FDA-approved drug and does not have an FDA-approved therapeutic indication.
FDA PCAC Update — July 2026
TB-500 free base and TB-500 acetate were considered by FDA’s Pharmacy Compounding Advisory Committee as part of the process for evaluating substances for possible inclusion on the Section 503A Bulks List.
The committee issued a favorable recommendation for possible inclusion.
Advisory committee recommendations are non-binding and are separate from FDA drug approval.
Compounding Review ≠ FDA Approval
Consideration for the Section 503A Bulks List does not establish that TB-500 is safe or effective for a particular clinical condition and does not convert TB-500 into an FDA-approved drug.
Competitive Sports
Prohibited in WADA-Tested Sport
TB-500 is included on the current World Anti-Doping Agency Prohibited List. Competitive athletes subject to WADA rules should not assume that a peptide is permitted simply because it is discussed in medical or wellness settings.
Frequently Asked Questions
What is TB-500?
TB-500 is a synthetic seven-amino-acid peptide investigated within tissue-repair and cell-migration biology.
Is TB-500 mainly a pain medication?
No. The interest surrounding TB-500 relates more to cellular migration, tissue organization, and repair biology than to directly blocking pain perception.
Does TB-500 heal tendons or ligaments?
TB-500 is commonly discussed for musculoskeletal recovery, but controlled human trials have not established that it reliably accelerates tendon or ligament healing.
Has TB-500 been studied in humans?
FDA’s 2026 review reported that it did not identify published clinical studies involving administration of TB-500 to humans for treatment of a disease or condition.
Is TB-500 FDA approved?
No. TB-500 does not currently have an FDA-approved therapeutic indication.
Can athletes use TB-500?
Athletes competing under WADA rules should be aware that TB-500 is prohibited.
The Bigger Picture
Recovery requires the body to regulate inflammation, deliver oxygen and nutrients, move repair cells into injured tissue, produce new extracellular matrix, and progressively remodel that tissue.
Peptide signaling may influence parts of this process, but it cannot replace the biological inputs required for functional recovery.
Recovery Requires More Than Pain Relief
The goal isn’t simply to make an injury feel better. The goal is to create the environment needed to repair tissue, restore strength, and progressively return that tissue to normal function.
Biology helps rebuild the tissue. Rehabilitation helps make it usable.Interested in Recovery & Regeneration?
Schedule a personalized wellness consultation to discuss your injury, recovery goals, health history, rehabilitation, nutrition, and available options.
Book a Wellness ConsultationSelected Scientific & Regulatory References
FDA evaluation of TB-500 free base and TB-500 acetate for consideration on the Section 503A Bulks List.
View FDA Briefing Document →
Pharmacy Compounding Advisory Committee meeting materials and evaluation of TB-500-related bulk drug substances.
View FDA Meeting Information →
Better recovery starts with better biology
If you want help understanding recovery, inflammation, performance, or peptide education in a broader wellness context, schedule a consultation.